← back to search

Sébastien P. Tabruyn

TransCure BioServices (France) · FR
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, CAR-T cell therapy research, Cancer, Hypoxia, and Metabolism, and Virus-based gene therapy research.
h-index
28
citations
3,091
works
114
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD‐1 blockade
Clinical and Translational Medicine 2024cited by 20position: middledoi
GATA2 is required for lymphatic vessel valve development and maintenance
Journal of Clinical Investigation 2015cited by 230position: middledoi
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
Nature Medicine 2014cited by 105position: middledoi
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Journal of Clinical Investigation 2013cited by 492position: middledoi
Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
Cancer Discovery 2012cited by 416position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2013–2014)— · 2 papers (2013–2014)— · 2 papers (2013–2014)— · 2 papers (2013–2014)— · 1 papers (2014–2014)Cansaran Saygili Demir · University of Lausanne1 papers (2015–2015)Barbara Sennino · Sunesis (United States)1 papers (2012–2012)Melanie Ricke‐Hoch · Medizinische Hochschule Hannover1 papers (2013–2013)— · 1 papers (2014–2014)Yan Agalarov · University of Lausanne1 papers (2015–2015)Mieke Dewerchin · Khalifa University of Science and Technology1 papers (2014–2014)Harold A. Chapman · Pulmonary and Allergy Associates1 papers (2012–2012)Karen Sliwa · World Heart Federation1 papers (2013–2013)Toshina Ishiguro‐Oonuma · Iwate University1 papers (2012–2012)Hamish S. Scott · South Australia Pathology1 papers (2015–2015)Genevieve A. Secker · University of London1 papers (2015–2015)Ivo Cornelissen · Johnson & Johnson (United States)1 papers (2014–2014)Drew L. Sutton · Flinders University1 papers (2015–2015)Vincent Lambert · KU Leuven1 papers (2013–2013)Peter Carmeliet · KU Leuven1 papers (2014–2014)